Pharmaceutical

Generate:Biomedicines secures $273m to advance therapeutic portfolio 

Generate:Biomedicines has secured $273m in Series C financing round to expedite its generative AI therapeutics portfolio.

Sep 15, 2023 - 20:00
Generate:Biomedicines secures $273m to advance therapeutic portfolio 
Generate:Biomedicines has secured $273m in Series C financing round to expedite its generative AI therapeutics portfolio.
Read the original article

Tags:

Previous Article

Market cap rebound by top 20 biopharmaceutical companies in Q2 2023

Next Article

No more cookies: How healthcare companies can gain trust for data consent

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

ESCMID 2024: Using AI in infection prevention and control

ESCMID 2024: Using AI in infection prevention and control

Apr 29, 2024

STAT+: AstraZeneca buys early-stage gene therapies from Pfizer in boon for struggling field

STAT+: AstraZeneca buys early-stage gene therapies from...

Jul 28, 2023

STAT+: LabCentral, a crucial Boston incubator for drug discovery, is slated to grow amid industry slowdown

STAT+: LabCentral, a crucial Boston incubator for drug ...

Jan 2, 2024